Translation of a mobility assessment tool for healthy children into Urdu

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on translating the Revised High-Level Mobility Assessment Tool (HiMAT) into Urdu to assess high-level mobility in healthy children aged 5-12 years. The translation process involves forward and backward translation by bilingual translators, synthesis of the translated versions, and evaluation by an expert committee. The final translated tool will undergo testing for validity and reliability to ensure it accurately measures mobility in the target population. The psychometric properties of the tool will be analyzed to confirm its effectiveness for clinical use.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Children with age group 5-12 years
* No condition affecting mobility of children
* Able to understand and follow instruction.
* Can speak \& understand language

Exclusion Criteria:

* Children with visual impairments.
* Children with conditions affecting their mobility.
* Children with any history of surgery in the past one year.
* Children with any cardiorespiratory comorbidities.
* Children with muscle strain, ligament sprain or joint laxity in lower extremities.
* Cognition less than 20 on Mini Mental State Examination (MMSE).
* Children with any history of any foot deformity

Where it's running

• Riphah International University
  Lahore, Punjab Province, Pakistan Recruiting

Study contacts

• Principal investigator: Shazia Muheen, MS — Riphah International University
• Study coordinator: Imran Amjad, PhD
• Email: imran.amjad@riphah.edu.pk
• Phone: +9233224390125

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Prevention with PMBL for recurrent RTIs in kids

  This study tests whether PMBL sublingual tablets can help prevent recurrent respiratory tract infections in children aged 3–12 compared to a placebo.

  Recruiting at 9 sites Phase 4 Lallemand Pharma AG · Bialystok and 9 other locations · NCT07578012

• Bifidobacterium XLTG11 to support growth, immune health, and reduce allergies in infants at higher allergy risk

  This trial tests whether daily Bifidobacterium animalis subsp. lactis XLTG11 for 180 days can reduce allergic, respiratory, and gastrointestinal symptoms and change gut microbiome and immune markers in infants under 3 with higher allergy risk.

  Recruiting Phase 2 Universiti Sains Malaysia · Pudong, Shanghai Municipality and 1 other locations · NCT07490587

• Outdoor science education to improve learning and well-being in primary school children

  This project will test whether giving 5th and 6th grade students outdoor science lessons instead of indoor lessons helps their learning, connection to nature, eco-anxiety, and stress.

  Recruiting Université de Sherbrooke · Montreal, Quebec · NCT07147634

• Functional training versus dynamic play to improve motor skills, fitness, and balance in 7–10-year-old children

  This trial will test whether functional training or dynamic play better improves gross motor skills, physical fitness, and balance in healthy children aged 7–10.

  Recruiting Riphah International University · Lahore, Punjab Province · NCT07005440

• Comparing physical health in children with esophageal atresia and healthy peers

  This study looks at how the physical health of children with esophageal atresia compares to that of healthy kids to see how the condition affects things like strength, exercise, and overall well-being.

  Recruiting Hacettepe University · Ankara, Ankara · NCT06975982

• Hand and Bimanual Therapy in a VR game for children with cerebral palsy

  This study tests whether a VR-based hand therapy program called HABIT-VR can improve hand function in children aged 6–17 with cerebral palsy, compared to a standard VR HABIT-VR approach.

  Recruiting University of Nebraska · Omaha, Nebraska · NCT06818877

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.